Anticancer and Anti-Inflammatory Activity of Probiotic Lactococcus lactis NK34
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
The anticancer and anti-inflammatory activities of probiotic Lactococcus lactis NK34 were demonstrated. Treatment of cancer cells such as SK-MES-1, DLD-1, HT-29, LoVo, AGS, and MCF-7 cells with 106 CFU/well of L. lactis NK34 resulted in strong inhibition of proliferation (>77% cytotoxicity, p < 0.05). The anti-inflammatory activity of L. lactis NK34 was also demonstrated in lipopolysaccharide-induced RAW 264.7 cells, where the production of nitric oxide and proinflammatory cytokines (tumor necrosis factor-α, interleukin-18, and cyclooxygenase-2) was reduced. These results suggest that L. lactis NK34 could be used as a probiotic microorganism to inhibit the proliferation of cancer cells and production of proinflammatory cytokines.
Abstract
The anticancer and anti-inflammatory activities of probiotic Lactococcus lactis NK34 were demonstrated. Treatment of cancer cells such as SK-MES-1, DLD-1, HT-29, LoVo, AGS, and MCF-7 cells with 106 CFU/well of L. lactis NK34 resulted in strong inhibition of proliferation (>77% cytotoxicity, p < 0.05). The anti-inflammatory activity of L. lactis NK34 was also demonstrated in lipopolysaccharide-induced RAW 264.7 cells, where the production of nitric oxide and proinflammatory cytokines (tumor necrosis factor-α, interleukin-18, and cyclooxygenase-2) was reduced. These results suggest that L. lactis NK34 could be used as a probiotic microorganism to inhibit the proliferation of cancer cells and production of proinflammatory cytokines.
참고문헌 (16)
- Baumgart DC, "Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease", Clin. Exp. Immunol, 157, pp.423~436 (2009)
- Commane D, "The potential mechanisms involved in the anti-carcinogenic action of probiotics", Mut. Res, 591, pp.276~289 (2005)
- Chang JH, "Probiotic characteristics of lactic acid isolated from kimchi", J. Appl. Microbiol, 109, pp.220~230 (2010)
- Festen EAM, "Inflammatory bowel disease and celiac disease: overlaps in the pathology and genetics, and their potential drug targets. Curr. Drug Targets Immune Endocr", Metab. Disord, 9, pp.199~218 (2009)
- Heo WS, "Effects of dietary probiotic, Lactococcus lactis subsp. lactis I2, supplementation on the growth and immune response of olive flounder (Paralichthys olivaceus)", Aquaculture, 376(379), pp.20~24 (2013)
- Lakatos L, "Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe?", Postgrad. Med. J, 82, pp.332~337 (2006)
- 박현동, "Potential Probiotic Properties of Lactococcus lactis NK34 Isolated from Jeotgal", Food Science and Biotechnology, 16(5), pp.843~847 (2007), 한국식품과학회
- Lee NK, "Probiotic potential of Lactobacillus strains with anti-allergic effects from kimchi for yogurt starters", LWT Food Sci. Technol, 58, pp.130~134 (2014)
- Lee NK, "The prophylactic effect of probiotic Bacillus polyfermenticus KU3 against cancer cells", J. Funct. Foods, 14, pp.513~518 (2015)
- Marcinkiewicz J, "Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria", Int. J. Exp. Pathol, 88, pp.155~164 (2007)
- O’Sullivan GC, "Probiotics: an emerging therapy", Curr. Pharm. Des, 11, pp.3~10 (2005)
- Otte JM, "Probiotics regulate the expression of COX-2 in intestinal epithelial cells", Nutr. Cancer, 61, pp.103~113 (2009)
- Ouwehand AC, "Allergenic effects of probiotics", J. Nutr, 137, pp.794S~797S (2011)
- Shukla R, "Leuconostoc mesenteroides NRRL B-1149 as probiotic and its dextran with anticancer properties", J. Biosci. Biotechnol, 3, pp.79~87 (2014)
- Westbrook AM, "Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models", Mutat. Res, 705, pp.40~59 (2010)
- Zhou X, "Inhibition ability of probiotic, Lactococcus lactis, against A. hydrophila and study of its immunostimulatory effect in tilapia (Oreochromis niloticus)", Int. J. Eng. Sci. Technol, 2, pp.73~80 (2010)